10/17/2024
3:54 PM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 15-12G | |
10/04/2024
3:21 PM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form S-8 POS | |
10/04/2024
3:24 PM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form S-8 POS | |
10/04/2024
3:27 PM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form S-8 POS | |
10/04/2024
3:30 PM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form S-8 POS | |
10/04/2024
3:33 PM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form S-8 POS | |
10/04/2024
3:36 PM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form S-8 POS | |
10/04/2024
3:18 PM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form S-8 POS | |
10/04/2024
3:16 PM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form POSASR | |
08/27/2024
9:14 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/15/2024
3:30 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC 13D/A | |
Get the Latest News and Ratings for MOR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for MorphoSys and its competitors with MarketBeat's FREE daily newsletter. |
08/13/2024
3:31 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
08/07/2024
3:51 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
| Form SC 14D9/A | |
08/07/2024
3:30 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
08/05/2024
7:14 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/02/2024
3:30 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
08/01/2024
3:30 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/31/2024
3:30 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/30/2024
3:30 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/29/2024
3:30 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/25/2024
3:30 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/25/2024
3:05 PM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 25
Notification of the removal from listing and registration of matured, redeemed or retired securities | |
07/18/2024
3:30 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/18/2024
10:25 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/12/2024
3:20 PM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/11/2024
3:30 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/05/2024
5:48 AM | MorphoSys (Subject)
MorphoSys AG (Subject)
| Form SC 14D9 | |
07/05/2024
5:02 AM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T | |
07/02/2024
9:18 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/21/2024
3:30 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC 13D/A | |
06/21/2024
9:07 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/20/2024
3:41 PM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/20/2024
3:33 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
| Form SC14D9C | |
06/20/2024
2:38 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-C | |
06/17/2024
3:30 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC 13D/A | |
06/10/2024
3:30 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC 13D/A | |
06/10/2024
11:06 AM | GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
MorphoSys (Subject)
MorphoSys AG (Subject)
| Form SC 13G/A | |
06/10/2024
10:01 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/06/2024
3:36 PM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/05/2024
9:22 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/04/2024
3:30 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
Silicon Valley Gold Rush (Ad) A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.”
Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free. Gates and Altman are betting big—see why |
06/04/2024
9:17 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/31/2024
9:17 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/29/2024
9:17 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/28/2024
9:16 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/24/2024
9:13 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/23/2024
1:19 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
| Form SC 14D9/A | |
05/23/2024
9:11 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/23/2024
8:04 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/21/2024
9:07 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/17/2024
9:15 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/16/2024
3:43 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
| Form SC 14D9/A | |
05/16/2024
3:31 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
05/16/2024
9:11 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/15/2024
9:09 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/14/2024
9:27 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/13/2024
9:19 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/10/2024
9:31 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/08/2024
9:08 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/07/2024
3:45 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
05/07/2024
9:24 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/06/2024
3:30 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
05/06/2024
9:07 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
